Related Experiment Video
Updated: Jun 5, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Inhibition of miR-4763-3p expression activates the PI3K/mTOR/Bcl2 autophagy signaling pathway to ameliorate cognitive
Wenxin Qi1,2, Yiwei Ying1,2, Peiru Wu1
1School of Life Sciences, Shanghai University, Shanghai, China.
Abstract:
Cognitive decline and memory impairment are subsequently result in neuronal apoptosis and synaptic damage. Aberrant regulation of microRNAs has been implicated in the pathogenesis of Alzheimer's disease (AD) and may play a pivotal role in the early stages of the disease. In this study, we identified the critical role of miR-4763-3p in AD pathogenesis, focusing on early-stage mild cognitive impairment (AD-MCI). Leveraging fluorescence in situ hybridization, we observed miR-4763-3p upregulation in AD hippocampal tissue, colocalizing with Aβ and Tau. Antagomir-mediated inhibition of miR-4763-3p ameliorated cognitive decline in AD-MCI mice. RNA-seq and functional assays revealed that miR-4763-3p targets ATP11A, and antagomir enhancing inward flipping of the "eat me" phosphatidylserine signal on the surface of neuronal cells, autophagy, and clearance of Aβ/lipofuscin, while reducing neuroinflammation and neuronal apoptosis. Mechanistically, miR-4763-3p modulates the PI3K/AKT/mTOR/Bcl2 pathway, thereby promoting neuronal autophagy and reducing apoptotic crosstalk. These findings underscore miR-4763-3p as a therapeutic target for AD-MCI, offering a novel strategy to enhance neuronal autophagy, alleviate inflammation, and improve cognitive function.
Insights
MicroRNA miR-4763-3p is upregulated in Alzheimer's disease mild cognitive impairment (AD-MCI). Inhibiting this microRNA in mice improved cognitive function by reducing neuroinflammation and neuronal apoptosis.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Alzheimer's disease (AD) involves cognitive decline, memory impairment, neuronal apoptosis, and synaptic damage.
- Aberrant microRNA regulation is implicated in AD pathogenesis, particularly in early stages like mild cognitive impairment (AD-MCI).
Purpose of the Study:
- To identify the role of miR-4763-3p in AD pathogenesis, specifically in AD-MCI.
- To investigate miR-4763-3p as a potential therapeutic target for AD-MCI.
Main Methods:
- Fluorescence in situ hybridization to detect miR-4763-3p in AD hippocampal tissue.
- Antagomir-mediated inhibition of miR-4763-3p in AD-MCI mouse models.
- RNA-sequencing and functional assays to identify miR-4763-3p targets and pathways.
Main Results:
- miR-4763-3p was upregulated in AD hippocampal tissue, colocalizing with Aβ and Tau.
- Inhibition of miR-4763-3p ameliorated cognitive decline in AD-MCI mice.
- miR-4763-3p targets ATP11A, promotes neuronal apoptosis, and modulates the PI3K/AKT/mTOR/Bcl2 pathway.
Conclusions:
- miR-4763-3p plays a critical role in AD-MCI pathogenesis.
- Inhibiting miR-4763-3p enhances neuronal autophagy, facilitates Aβ/lipofuscin clearance, reduces neuroinflammation and apoptosis, and improves cognitive function.
- miR-4763-3p represents a promising therapeutic target for AD-MCI.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity

